Gilead and MacroGenics Announce Oncology Collaboration to Develop Bispecific Antibodies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/27/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. CRL

Go back to Gilead and MacroGenics Announce Oncology Collaboration to Develop Bispecific Antibodies

Macrogenics (MGNX) Climbs 40% Following Pact with Gilead Sciences (GILD)

October 17, 2022 7:37 AM EDT

Macrogenics (NASDAQ: MGNX) Climbs 40% Following Pact with Gilead Sciences (NASDAQ: GILD)

... More